Charles River Laboratories published a new whitepaper tackling key potency challenges across preclinical, clinical, and commercial stages, in vivo, in vitro, and emerging non-animal methodologies.
Public source
Publisher name
Public post
Developing a vaccine is tough, but proving its consistency is tougher. Our new whitepaper tackles key potency challenges and offers practical insights for CMC strategy a…
Company
Charles River Laboratories
Together, We Create Healthier Lives
- Industry
- Biotechnology Research
- Location
- Wilmington, US
- Company size
- 10,001+ employees
About Charles River Laboratories
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
See moreLatest activity
Latest activity from Charles River Laboratories
47 signals
Products & Services
Charles River Laboratories released a fully automated cartridge production suite for bacterial endotoxin testing to drive greater quality, efficiency, traceability, and scalability.
People
Charles River Laboratories welcomed interns like Nokutenda Chelsea Choto to gain hands-on experience while discovering the people, culture, and sense of community that make Charles River special.
Research & Knowledge
Charles River Laboratories launched The DART Board, a new EurekaBlog series spotlighting topics in developmental and reproductive toxicology, including the inaugural article Why Every Ovarian Follicle Count Matters.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Rapid Micro Biosystems
Rapid Micro Biosystems published a whitepaper exploring how microbial quality control can become a strategic advantage for CDMOs.
Research & Knowledge
3Biotech
3Biotech published a Drug Development Roadmap whitepaper including practical guidance and downloadable Gantt charts to help visualize the journey from discovery to first-in-human studies.
Research & Knowledge
Cytiva
Cytiva published an article exploring how tailored validation services can help reduce risk while conserving valuable material for low and ultra-low volume processes.
Research & Knowledge
Culture Biosciences
Culture Biosciences published a new white paper titled Accelerate Bioprocess Development with Culture Console.
Research & Knowledge
Eurofins Discovery